Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
4
Taylor Morrison Home
TMHC
5
KB Home
KBH
US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 0.939
- -0.050-5.02%
Close Mar 28 16:00 ET
- 0.925
- -0.014-1.50%
Post 19:02 ET
87.34MMarket Cap-0.57P/E (TTM)
1.000High0.925Low644.46KVolume0.993Open0.989Pre Close610.91KTurnover0.77%Turnover RatioLossP/E (Static)93.00MShares5.15052wk High0.35P/B78.83MFloat Cap0.88052wk Low--Dividend TTM83.94MShs Float32.645Historical High--Div YieldTTM7.57%Amplitude0.880Historical Low0.947Avg Price1Lot Size
Caribou Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -71.01%9.99M | -41.62%2.08M | -91.45%2.02M | -7.75%3.46M | -30.64%2.43M | 148.91%34.48M | -3.63%3.56M | 616.38%23.66M | -10.42%3.76M | 31.46%3.5M |
| Operating revenue | -71.01%9.99M | -41.62%2.08M | -91.45%2.02M | -7.75%3.46M | -30.64%2.43M | 148.91%34.48M | -3.63%3.56M | 616.38%23.66M | -10.42%3.76M | 31.46%3.5M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 17.32%176.61M | -0.12%40.95M | 5.14%40.26M | 28.24%46.97M | 39.90%48.43M | 25.19%150.54M | 19.64%41M | 28.33%38.3M | 12.26%36.62M | 47.20%34.62M |
| Selling and administrative expenses | 20.79%46.46M | 7.89%10.49M | 1.34%9.84M | 13.49%11.49M | 64.36%14.64M | 1.16%38.46M | 13.91%9.72M | -1.40%9.71M | 0.76%10.12M | -7.13%8.91M |
| -General and administrative expense | 20.79%46.46M | 7.89%10.49M | 1.34%9.84M | 13.49%11.49M | 64.36%14.64M | 1.16%38.46M | 13.91%9.72M | -1.40%9.71M | 0.76%10.12M | -7.13%8.91M |
| Research and development costs | 16.13%130.15M | -2.61%30.46M | 6.43%30.42M | 33.87%35.48M | 31.42%33.79M | 36.29%112.08M | 21.54%31.28M | 42.98%28.58M | 17.38%26.5M | 84.64%25.71M |
| Operating profit | -43.56%-166.62M | -3.83%-38.88M | -161.31%-38.24M | -32.35%-43.5M | -47.84%-46M | -9.08%-116.06M | -22.45%-37.44M | 44.86%-14.63M | -15.61%-32.87M | -49.22%-31.12M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 23.41%17.5M | 7.86%3.38M | -23.26%3.55M | 73.31%5.8M | 55.21%4.77M | 101.22%14.18M | -14.46%3.13M | 4,310.00%4.63M | 93.14%3.35M | 74.05%3.07M |
| Gain on sale of security | ---- | ---- | -250.00%-14K | -563.64%-102K | ---- | ---- | ---- | -112.90%-4K | 237.50%22K | 82.95%-15K |
| Other non- operating income (expenses) | 23.41%17.5M | 4.05%3.26M | -23.02%3.57M | 77.52%5.91M | 54.45%4.77M | 97.49%14.18M | -15.76%3.13M | 3,387.23%4.64M | 90.11%3.33M | 66.59%3.09M |
| Income before tax | -46.37%-149.11M | -3.46%-35.5M | -246.77%-34.68M | -27.70%-37.7M | -47.03%-41.23M | -2.54%-101.88M | -27.46%-34.31M | 62.46%-10M | -10.57%-29.52M | -46.92%-28.04M |
| Income tax | -104.66%-9K | 175.71%193K | ||||||||
| Net income | -46.08%-149.11M | -2.85%-35.49M | -246.77%-34.68M | -27.70%-37.7M | -47.03%-41.23M | -2.66%-102.07M | -27.85%-34.51M | 62.46%-10M | -10.57%-29.52M | -46.92%-28.04M |
| Net income continuous Operations | -46.08%-149.11M | -2.85%-35.49M | -246.77%-34.68M | -27.70%-37.7M | -47.03%-41.23M | -2.66%-102.07M | -27.85%-34.51M | 62.46%-10M | -10.57%-29.52M | -46.92%-28.04M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -46.08%-149.11M | -2.85%-35.49M | -246.77%-34.68M | -27.70%-37.7M | -47.03%-41.23M | -2.66%-102.07M | -27.85%-34.51M | 62.46%-10M | -10.57%-29.52M | -46.92%-28.04M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -46.08%-149.11M | -2.85%-35.49M | -246.77%-34.68M | -27.70%-37.7M | -47.03%-41.23M | -2.66%-102.07M | -27.85%-34.51M | 62.46%-10M | -10.57%-29.52M | -46.92%-28.04M |
| Basic earnings per share | -19.57%-1.65 | 2.50%-0.39 | -216.67%-0.38 | 12.50%-0.42 | 0.00%-0.46 | 15.85%-1.38 | 9.09%-0.4 | 72.73%-0.12 | -9.09%-0.48 | -43.75%-0.46 |
| Diluted earnings per share | -19.57%-1.65 | 2.50%-0.39 | -216.67%-0.38 | 12.50%-0.42 | 0.00%-0.46 | 15.85%-1.38 | 9.09%-0.4 | 72.73%-0.12 | -9.09%-0.48 | -43.75%-0.46 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings